$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 0.00 | 1,767 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 0.00 | 10,000 | 0 | 1,767 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 41.34 | 26,799 | 1,107,871 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 36.90 | 23,437 | 864,825 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 24.87 | 17,047 | 423,959 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 22.60 | 30,405 | 687,153 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 18.85 | 32,113 | 605,330 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 18.01 | 12,919 | 232,671 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.54 | 28,649 | 473,854 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.02 | 12,198 | 195,412 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 15.03 | 11,000 | 165,330 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 9.02 | 18,750 | 169,125 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 41.34 | 3,201 | 132,329 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | H | 36.90 | 1,563 | 57,675 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 24.87 | 1,953 | 48,571 | 1,000 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 22.60 | 4,482 | 101,293 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 18.01 | 7,081 | 127,529 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.54 | 5,251 | 86,852 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 16.02 | 7,802 | 124,988 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 15.03 | 5,000 | 75,150 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Option Exercise | J | 9.02 | 6,250 | 56,375 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 1,360 | 42,160 | 0 | 1.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 6,614 | 205,034 | 1,360 | 8 K to 1.4 K (-82.94 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 3,192 | 98,952 | 0 | 3.2 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 473 | 14,663 | 3,192 | 3.7 K to 3.2 K (-12.91 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 35,014 | 1,085,434 | 0 | 35 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP, Chief Complianc ... | Sell | J | 31.00 | 412 | 12,772 | 35,014 | 35.4 K to 35 K (-1.16 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 0.00 | 40,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 41.34 | 46,799 | 1,934,671 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 36.90 | 67,289 | 2,482,964 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 24.87 | 65,980 | 1,640,923 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 22.60 | 34,884 | 788,378 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.85 | 23,722 | 447,160 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.01 | 44,243 | 796,816 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.54 | 35,475 | 586,757 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.02 | 112,207 | 1,797,556 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 15.03 | 70,843 | 1,064,770 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 9.02 | 56,248 | 507,357 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 41.34 | 3,201 | 132,329 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | H | 36.90 | 2,711 | 100,036 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 24.87 | 4,020 | 99,977 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 22.60 | 5,116 | 115,622 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.85 | 8,361 | 157,605 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 18.01 | 5,757 | 103,684 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.54 | 4,525 | 74,844 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 16.02 | 7,793 | 124,844 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 15.03 | 9,157 | 137,630 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Option Exercise | J | 9.02 | 3,752 | 33,843 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 110 | 3,410 | 0 | 110 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 2,889 | 89,559 | 0 | 2.9 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 5,085 | 157,635 | 2,889 | 8 K to 2.9 K (-63.77 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 3,415 | 105,865 | 0 | 3.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 453 | 14,043 | 3,415 | 3.9 K to 3.4 K (-11.71 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | J | 31.00 | 64,702 | 2,005,762 | 0 | 64.7 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 65,115 | 2,018,565 | 64,702 | 129.8 K to 64.7 K (-50.16 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Sell | U | 31.00 | 8,255 | 255,905 | 129,817 | 138.1 K to 129.8 K (-5.98 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | SVP, Chief Financia ... | Buy | J | 31.00 | 64,702 | 2,005,762 | 138,072 | 73.4 K to 138.1 K (+88.19 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 0.00 | 100,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 0.00 | 37,917 | 0 | 100,000 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 0.00 | 317,500 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | H | 47.73 | 30,000 | 1,431,900 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | H | 41.34 | 117,582 | 4,860,840 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | H | 36.90 | 447,289 | 16,504,964 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 24.87 | 270,980 | 6,739,273 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 22.60 | 95,576 | 2,160,018 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 18.85 | 93,194 | 1,756,707 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 18.01 | 244,448 | 4,402,508 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 16.54 | 103,838 | 1,717,481 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 16.02 | 293,758 | 4,706,003 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 15.03 | 243,347 | 3,657,505 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 9.02 | 188,912 | 1,703,986 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | H | 41.34 | 2,418 | 99,960 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | H | 36.90 | 2,711 | 100,036 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 24.87 | 4,020 | 99,977 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 22.60 | 4,424 | 99,982 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 18.85 | 6,806 | 128,293 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 18.01 | 5,552 | 99,992 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 16.54 | 6,162 | 101,919 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 16.02 | 6,242 | 99,997 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 15.03 | 6,653 | 99,995 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | J | 9.02 | 11,088 | 100,014 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 14,460 | 448,260 | 0 | 14.5 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 9,463 | 293,353 | 14,460 | 23.9 K to 14.5 K (-39.56 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 36,931 | 1,144,861 | 0 | 36.9 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 4,519 | 140,089 | 0 | 4.5 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 3,455 | 107,105 | 4,519 | 8 K to 4.5 K (-43.33 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 13,003 | 403,093 | 0 | 13 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 453 | 14,043 | 13,003 | 13.5 K to 13 K (-3.37 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 42,897 | 1,329,807 | 0 | 42.9 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 3,327 | 103,137 | 0 | 3.3 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | U | 31.00 | 94,618 | 2,933,158 | 3,327 | 97.9 K to 3.3 K (-96.60 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Sell | J | 31.00 | 215,526 | 6,681,306 | 97,945 | 313.5 K to 97.9 K (-68.75 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Buy | J | 31.00 | 215,526 | 6,681,306 | 313,471 | 97.9 K to 313.5 K (+220.05 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 0.00 | 40,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | H | 41.27 | 40,648 | 1,677,543 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 24.87 | 50,999 | 1,268,345 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 18.01 | 53,669 | 966,579 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 16.02 | 101,035 | 1,618,581 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 15.03 | 52,593 | 790,473 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 9.02 | 79,954 | 721,185 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | H | 41.27 | 9,352 | 385,957 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 24.87 | 4,001 | 99,505 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 18.01 | 6,331 | 114,021 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 16.02 | 8,965 | 143,619 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 15.03 | 7,407 | 111,327 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Option Exercise | J | 9.02 | 5,046 | 45,515 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Sell | J | 31.00 | 1,360 | 42,160 | 0 | 1.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Sell | J | 31.00 | 6,614 | 205,034 | 1,360 | 8 K to 1.4 K (-82.94 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Sell | J | 31.00 | 1,161 | 35,991 | 0 | 1.2 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Sell | J | 31.00 | 926 | 28,706 | 1,161 | 2.1 K to 1.2 K (-44.37 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Sell | J | 31.00 | 412 | 12,772 | 0 | 412 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | SVP, Chief Administ ... | Sell | J | 31.00 | 62,057 | 1,923,767 | 412 | 62.5 K to 412 (-99.34 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 47.83 | 20,000 | 956,600 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | H | 47.83 | 26,640 | 1,274,191 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 24.87 | 18,747 | 466,238 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 18.01 | 16,863 | 303,703 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 16.02 | 90,448 | 1,448,977 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 15.03 | 41,386 | 622,032 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 9.02 | 17,186 | 155,018 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | H | 47.83 | 8,360 | 399,859 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 24.87 | 1,253 | 31,162 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 18.01 | 6,437 | 115,930 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 16.02 | 9,552 | 153,023 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 15.03 | 8,614 | 129,468 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Option Exercise | J | 9.02 | 7,814 | 70,482 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Sell | J | 31.00 | 4,227 | 131,037 | 0 | 4.2 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Sell | J | 31.00 | 3,159 | 97,929 | 4,227 | 7.4 K to 4.2 K (-42.77 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Sell | J | 31.00 | 727 | 22,537 | 0 | 727 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Sell | J | 31.00 | 6,361 | 197,191 | 0 | 6.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | LEONHARDT HARRY J | SVP, Legal, Compl & ... | Sell | J | 31.00 | 32,345 | 1,002,695 | 6,361 | 38.7 K to 6.4 K (-83.57 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 0.00 | 30,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | H | 37.75 | 29,404 | 1,110,001 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 24.87 | 42,855 | 1,065,804 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 18.01 | 63,096 | 1,136,359 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 16.02 | 82,447 | 1,320,801 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 10.53 | 23,931 | 251,993 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 9.02 | 89,403 | 806,415 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | H | 37.75 | 10,596 | 399,999 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 24.87 | 7,145 | 177,696 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 18.01 | 6,904 | 124,341 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 16.02 | 7,553 | 120,999 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 10.53 | 11,069 | 116,557 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Option Exercise | J | 9.02 | 5,597 | 50,485 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Sell | J | 31.00 | 2,990 | 92,690 | 0 | 3 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Sell | J | 31.00 | 4,984 | 154,504 | 2,990 | 8 K to 3 K (-62.50 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Sell | J | 31.00 | 473 | 14,663 | 0 | 473 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Sell | J | 31.00 | 1,632 | 50,592 | 473 | 2.1 K to 473 (-77.53 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | SVP, Operations | Sell | J | 31.00 | 31,723 | 983,413 | 0 | 31.7 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 0.00 | 85,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 18.01 | 48,968 | 881,914 | 0 |